Wave Life Sciences Ltd.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $42.7 | $108.3 | $113.3 | $3.6 | $41.0 |
| Operating income | -$215.4 | -$110.4 | -$68.0 | -$162.7 | -$127.0 |
| Net income | -$204.4 | -$97.0 | -$57.5 | -$161.8 | -$122.2 |
| Cash Flow Statement | |||||
| Free cash flow | -$188.2 | -$152.0 | -$20.5 | -$129.1 | -$89.6 |
Shares outstanding 197.0M · Free float 42.1%
Annual filing data through FY ended December 31, 2025; float as of October 1, 2026.